|
|
Noveris Health Sciences Inc
CSE •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 10/30/2026
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeCSE
Market Capitalization2.93 mln
Float54.67 mln
Earnings Date08/17/2026
Relative Strength
10
/ 100
Significantly lagging
Key Fundamentals
EPS2.61
P/E0.02
ROIC-10.00
ROA265
EBITDA, mln1.69
EV / EBITDA2.69
EV / EBIT2.69
Quote Details
Last
0.045
Change
0 (0%)
Open
0.045
Volume
90,479
Turnover
4,071.56
Average Volume
206,821
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
-10% |
34
/ 100
 |
| 1 Month |
-35.71% |
17
/ 100
 |
| 2 Months |
-96.25% |
0
/ 100
 |
| 6 Months |
-97.62% |
0
/ 100
|
|
| |
